TRACON Pharmaceuticals (TCON) Insider Trading & Ownership $0.07 -0.01 (-11.98%) (As of 10/11/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends TRACON Pharmaceuticals (NASDAQ:TCON) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.27%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$2.94 MNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$2,188.80 Get TCON Insider Trade Alerts Want to know when executives and insiders are buying or selling TRACON Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TCON Insider Buying and Selling by Quarter Ad Crypto 101 MediaNext opportunity for crypto millions"Uptober" is here, and it's not just a clever name. Historically, October ignites crypto's most explosive gains. This year could be off the charts. Don't let this opportunity pass you by. In crypto, timing is everything. Go here to discover the #1 crypto set to dominate Uptober. TRACON Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/26/2023Charles TheuerCEOBuy199$13.20$2,626.80 3/9/2023Opaleye Management Inc.Major ShareholderBuy8,725$27.60$240,810.00 2/28/2023Charles TheuerCEOBuy10$30.40$304.00 1/18/2023Charles TheuerCEOBuy340$32.40$11,016.00 12/14/2022Charles TheuerCEOBuy1,150$25.80$29,670.00 12/14/2022Opaleye Management Inc.Major ShareholderBuy8,375$25.00$209,375.00 Next opportunity for crypto millions (Ad)"Uptober" is here, and it's not just a clever name. Historically, October ignites crypto's most explosive gains. This year could be off the charts. Don't let this opportunity pass you by. In crypto, timing is everything. Go here to discover the #1 crypto set to dominate Uptober.12/6/2022Opaleye Management Inc.Major ShareholderSell76$28.80$2,188.80 11/18/2022Charles TheuerCEOBuy695$28.20$19,599.00 11/2/2022Charles TheuerCEOBuy300$31.80$9,540.00 10/18/2022Opaleye Management Inc.Major ShareholderBuy625$33.00$20,625.00 10/7/2022Charles TheuerCEOBuy250$35.40$8,850.00 10/3/2022Charles TheuerCEOBuy250$33.40$8,350.00 9/29/2022Opaleye Management Inc.Major ShareholderBuy470$34.80$16,356.00 9/27/2022Opaleye Management Inc.Major ShareholderBuy85$33.80$2,873.00 9/22/2022Charles TheuerCEOBuy250$35.20$8,800.00 9/22/2022Opaleye Management Inc.Major ShareholderBuy865$34.60$29,929.00 9/19/2022Opaleye Management Inc.Major ShareholderBuy250$37.40$9,350.00 9/12/2022Scott B BrownCFOBuy125$40.40$5,050.00 7/26/2022Opaleye Management Inc.Major ShareholderBuy112$34.40$3,852.80 7/22/2022Charles TheuerCEOBuy225$37.00$8,325.00 7/14/2022Opaleye Management Inc.Major ShareholderBuy359$36.20$12,995.80 7/12/2022Charles TheuerCEOBuy150$37.40$5,610.00 6/24/2022Opaleye Management Inc.Major ShareholderBuy570$27.80$15,846.00 6/21/2022Opaleye Management Inc.Major ShareholderBuy42,099$26.20$1,102,993.80 5/10/2022Opaleye Management Inc.Major ShareholderBuy485$35.20$17,072.00 5/9/2022Charles TheuerCEOBuy500$37.00$18,500.00 5/6/2022Charles TheuerCEOBuy125$39.40$4,925.00 4/29/2022Charles TheuerCEOBuy250$39.40$9,850.00 4/25/2022Opaleye Management Inc.Major ShareholderBuy538$43.60$23,456.80 4/22/2022Opaleye Management Inc.Major ShareholderBuy2,100$44.80$94,080.00 4/21/2022Charles TheuerCEOBuy225$46.00$10,350.00 4/13/2022Opaleye Management Inc.Major ShareholderBuy367$50.00$18,350.00 4/11/2022Opaleye Management Inc.Major ShareholderBuy455$48.40$22,022.00 4/8/2022Charles TheuerCEOBuy100$50.00$5,000.00 3/30/2022Charles TheuerCEOBuy200$54.00$10,800.00 3/29/2022Scott B BrownCFOBuy50$56.40$2,820.00 3/21/2022Charles TheuerCEOBuy60$49.00$2,940.00 1/28/2022Opaleye Management Inc.Major ShareholderBuy25$44.00$1,100.00 1/24/2022Opaleye Management Inc.Major ShareholderBuy868$41.00$35,588.00 1/21/2022Opaleye Management Inc.Major ShareholderBuy1,750$43.80$76,650.00 Next opportunity for crypto millions (Ad)"Uptober" is here, and it's not just a clever name. Historically, October ignites crypto's most explosive gains. This year could be off the charts. Don't let this opportunity pass you by. In crypto, timing is everything. Go here to discover the #1 crypto set to dominate Uptober.1/19/2022Opaleye Management Inc.Major ShareholderBuy1,184$44.80$53,043.20 12/29/2021Opaleye Management Inc.Major ShareholderBuy2,616$50.20$131,323.20 12/27/2021Opaleye Management Inc.Major ShareholderBuy4,366$58.40$254,974.40 12/15/2021Opaleye Management Inc.Major ShareholderBuy1,098$48.60$53,362.80 12/13/2021Opaleye Management Inc.Major ShareholderBuy760$52.80$40,128.00 12/6/2021Opaleye Management Inc.Major ShareholderBuy1,136$45.20$51,347.20 12/3/2021Opaleye Management Inc.Major ShareholderBuy4,463$46.00$205,298.00 11/18/2021Charles TheuerCEOBuy34$57.60$1,958.40 11/5/2021Charles TheuerCEOBuy200$68.20$13,640.00 (Data available from 1/1/2013 forward) TCON Insider Trading Activity - Frequently Asked Questions Who is on TRACON Pharmaceuticals's Insider Roster? The list of insiders at TRACON Pharmaceuticals includes Charles Theuer, Opaleye Management Inc., and Scott B Brown. Learn more on insiders at TCON. What percentage of TRACON Pharmaceuticals stock is owned by insiders? 5.27% of TRACON Pharmaceuticals stock is owned by insiders. Learn more on TCON's insider holdings. Which TRACON Pharmaceuticals insiders have been buying company stock? The following insiders have purchased TCON shares in the last 24 months: Charles Theuer ($72,755.80), and Opaleye Management Inc. ($470,810.00). How much insider buying is happening at TRACON Pharmaceuticals? Insiders have purchased a total of 20,419 TCON shares in the last 24 months for a total of $543,565.80 bought. Which TRACON Pharmaceuticals insiders have been selling company stock? The following insider sold TCON shares in the last 24 months: Opaleye Management Inc. ($2,188.80). How much insider selling is happening at TRACON Pharmaceuticals? Insiders have sold a total of 76 TRACON Pharmaceuticals shares in the last 24 months for a total of $2,188.80 sold. More Insider Trading Tools from MarketBeat Related Companies: 180 Life Sciences Insider Buying Cyclacel Pharmaceuticals Insider Buying Virpax Pharmaceuticals Insider Buying Revelation Biosciences Insider Buying Panbela Therapeutics Insider Buying PaxMedica Insider Buying Salarius Pharmaceuticals Insider Buying Evofem Biosciences Insider Buying Genprex Insider Buying Aptevo Therapeutics Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insiders Hold Tight as Helen of Troy Prepares for a Major ReboundInsiders Are Betting Big on These 2 StocksThis Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now This page (NASDAQ:TCON) was last updated on 10/12/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe Crypto Whisperer Just Sounded the AlarmThe 2024 Altcoin Eruption is Almost Here (Get in by Nov. 4) In late 2020, Ian King urged his readers to tak...Banyan Hill Publishing | SponsoredDon’t Miss Out: Elon’s Game-Changing InventionWhen you click here you'll discover what Elon Musk's newest invention can do… And how it works… You migh...InvestorPlace | SponsoredNext opportunity for crypto millionsAs we enter crypto's golden quarter (October-December), this coin is primed for takeoff. The best part? Mos...Crypto 101 Media | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRACON Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TRACON Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.